Anebulo Pharmaceuticals Inc (ANEB)
Official siteBIOTECHNOLOGY
Last updated: Nov 16, 2026 at 4:00 PM ET
Anebulo Pharmaceuticals Inc (ANEB) Stock Chart
Anebulo Pharmaceuticals (ANEB) closed at $0.26 on Nov 16, 2026. Its price fell 89.0% over the past 12 months. The month-end price fell 96.4% over the 5 years through Oct 2026, a compound annual decline of 48.5%.
Price Chart
From May 2021 to Oct 2026, its highest month-end close was $8.20 in May 2021 and its lowest $0.24 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ANEB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ANEB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 34.6%, and over 6 months it fell 49.0%. The month-end price fell 89.0% over the 3 years through Oct 2026, a compound annual decline of 52.1%.
| Period | Change |
|---|---|
| 1 month | +25,900.0% |
| 3 months | -34.6% |
| 6 months | -49.0% |
| 12 months | -89.0% |
| 12 months, with dividends | -89.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -89.0% | -52.1% |
| 5 years | -96.4% | -48.5% |
Price by Year
Its best calendar year was 2023, when the price fell 0.2%, and its weakest was 2022, when it fell 60.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.24 | -76.1% |
| 2025 | $1.01 | -39.9% |
| 2024 | $1.68 | -30.6% |
| 2023 | $2.42 | -0.2% |
| 2022 | $2.42 | -60.6% |
Trading Range
The price is 5.2% below its 50-day average of $0.27 and 38.5% below its 200-day average of $0.42.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 16, 2026) | $0.26 | |
| 50-day average | $0.27 | -5.2% |
| 200-day average | $0.42 | -38.5% |
Price Risk
Over 3 years, its largest fall from a peak was 100.0%.
| Measure | Value |
|---|---|
| 1-year beta | -3.70 |
| Largest fall, 1 year | -100.0% |
| Largest fall, 3 years | -100.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ANEB
What is ANEB's 1-year price change?
Anebulo Pharmaceuticals's price fell 89.0% over the past 12 months. With dividends included, the 12-month total return was -89.0%.
What is ANEB's 5-year price change?
Anebulo Pharmaceuticals's month-end price fell 96.4% over the 5 years through Oct 2026, a compound annual decline of 48.5%. These figures leave out dividends.
What is ANEB's beta?
Anebulo Pharmaceuticals's 1-year beta against the S&P 500 is -3.70, so its price has tended to move against the market over the past year. Its largest fall from a peak over the past year was 100.0%.
Is the ANEB chart free?
Yes. Advanced Charting for ANEB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ANEB pages: Overview, Charting, Financials